368 related articles for article (PubMed ID: 21706047)
1. Eya2 is required to mediate the pro-metastatic functions of Six1 via the induction of TGF-β signaling, epithelial-mesenchymal transition, and cancer stem cell properties.
Farabaugh SM; Micalizzi DS; Jedlicka P; Zhao R; Ford HL
Oncogene; 2012 Feb; 31(5):552-62. PubMed ID: 21706047
[TBL] [Abstract][Full Text] [Related]
2. Identification of a Small-Molecule Inhibitor That Disrupts the SIX1/EYA2 Complex, EMT, and Metastasis.
Zhou H; Blevins MA; Hsu JY; Kong D; Galbraith MD; Goodspeed A; Culp-Hill R; Oliphant MUJ; Ramirez D; Zhang L; Trinidad-Pineiro J; Mathews Griner L; King R; Barnaeva E; Hu X; Southall NT; Ferrer M; Gustafson DL; Regan DP; D'Alessandro A; Costello JC; Patnaik S; Marugan J; Zhao R; Ford HL
Cancer Res; 2020 Jun; 80(12):2689-2702. PubMed ID: 32341035
[TBL] [Abstract][Full Text] [Related]
3. The SIX1-EYA transcriptional complex as a therapeutic target in cancer.
Blevins MA; Towers CG; Patrick AN; Zhao R; Ford HL
Expert Opin Ther Targets; 2015 Feb; 19(2):213-25. PubMed ID: 25555392
[TBL] [Abstract][Full Text] [Related]
4. Regulation of cancer stem cell properties by SIX1, a member of the PAX-SIX-EYA-DACH network.
Kingsbury TJ; Kim M; Civin CI
Adv Cancer Res; 2019; 141():1-42. PubMed ID: 30691681
[TBL] [Abstract][Full Text] [Related]
5. Expression of Six1 in luminal breast cancers predicts poor prognosis and promotes increases in tumor initiating cells by activation of extracellular signal-regulated kinase and transforming growth factor-beta signaling pathways.
Iwanaga R; Wang CA; Micalizzi DS; Harrell JC; Jedlicka P; Sartorius CA; Kabos P; Farabaugh SM; Bradford AP; Ford HL
Breast Cancer Res; 2012 Jul; 14(4):R100. PubMed ID: 22765220
[TBL] [Abstract][Full Text] [Related]
6. Eya1 and Eya2 proteins are required for hypaxial somitic myogenesis in the mouse embryo.
Grifone R; Demignon J; Giordani J; Niro C; Souil E; Bertin F; Laclef C; Xu PX; Maire P
Dev Biol; 2007 Feb; 302(2):602-16. PubMed ID: 17098221
[TBL] [Abstract][Full Text] [Related]
7. The EGFR/miR-338-3p/EYA2 axis controls breast tumor growth and lung metastasis.
Liang Y; Xu X; Wang T; Li Y; You W; Fu J; Liu Y; Jin S; Ji Q; Zhao W; Song Q; Li L; Hong T; Huang J; Lyu Z; Ye Q
Cell Death Dis; 2017 Jul; 8(7):e2928. PubMed ID: 28703807
[TBL] [Abstract][Full Text] [Related]
8. Homeoprotein Six1 increases TGF-beta type I receptor and converts TGF-beta signaling from suppressive to supportive for tumor growth.
Micalizzi DS; Wang CA; Farabaugh SM; Schiemann WP; Ford HL
Cancer Res; 2010 Dec; 70(24):10371-80. PubMed ID: 21056993
[TBL] [Abstract][Full Text] [Related]
9. The miR-106b-25 cluster targets Smad7, activates TGF-β signaling, and induces EMT and tumor initiating cell characteristics downstream of Six1 in human breast cancer.
Smith AL; Iwanaga R; Drasin DJ; Micalizzi DS; Vartuli RL; Tan AC; Ford HL
Oncogene; 2012 Dec; 31(50):5162-71. PubMed ID: 22286770
[TBL] [Abstract][Full Text] [Related]
10. The Six1 homeoprotein induces human mammary carcinoma cells to undergo epithelial-mesenchymal transition and metastasis in mice through increasing TGF-beta signaling.
Micalizzi DS; Christensen KL; Jedlicka P; Coletta RD; Barón AE; Harrell JC; Horwitz KB; Billheimer D; Heichman KA; Welm AL; Schiemann WP; Ford HL
J Clin Invest; 2009 Sep; 119(9):2678-90. PubMed ID: 19726885
[TBL] [Abstract][Full Text] [Related]
11. Role of SIX1, EYA2, and E-cadherin in ovarian carcinoma. Evidence on epithelial-mesenchymal transition from an immunohistochemical study.
Dawoud MM; Aiad HAES; Tawfiq EAE; Al-Qalashy FSA; Eissa N; El-Rebey HS
Ann Diagn Pathol; 2021 Dec; 55():151815. PubMed ID: 34534789
[TBL] [Abstract][Full Text] [Related]
12. Structure-function analyses of the human SIX1-EYA2 complex reveal insights into metastasis and BOR syndrome.
Patrick AN; Cabrera JH; Smith AL; Chen XS; Ford HL; Zhao R
Nat Struct Mol Biol; 2013 Apr; 20(4):447-53. PubMed ID: 23435380
[TBL] [Abstract][Full Text] [Related]
13. Six1 promotes epithelial-mesenchymal transition and malignant conversion in human papillomavirus type 16-immortalized human keratinocytes.
Xu H; Zhang Y; Altomare D; Peña MM; Wan F; Pirisi L; Creek KE
Carcinogenesis; 2014 Jun; 35(6):1379-88. PubMed ID: 24574515
[TBL] [Abstract][Full Text] [Related]
14. miR-30a suppresses breast cancer cell proliferation and migration by targeting Eya2.
Fu J; Xu X; Kang L; Zhou L; Wang S; Lu J; Cheng L; Fan Z; Yuan B; Tian P; Zheng X; Yu C; Ye Q; Lv Z
Biochem Biophys Res Commun; 2014 Mar; 445(2):314-9. PubMed ID: 24508260
[TBL] [Abstract][Full Text] [Related]
15. Two naturally derived small molecules disrupt the sineoculis homeobox homolog 1-eyes absent homolog 1 (SIX1-EYA1) interaction to inhibit colorectal cancer cell growth.
Wu J; Huang B; He HB; Lu WZ; Wang WG; Liu H
Chin Med J (Engl); 2021 Sep; 134(19):2340-2352. PubMed ID: 34561318
[TBL] [Abstract][Full Text] [Related]
16. Aberrant expression of homeobox gene SIX1 in Hodgkin lymphoma.
Nagel S; Meyer C; Kaufmann M; Drexler HG; MacLeod RA
Oncotarget; 2015 Nov; 6(37):40112-26. PubMed ID: 26473286
[TBL] [Abstract][Full Text] [Related]
17. Eya2 overexpression promotes the invasion of human astrocytoma through the regulation of ERK/MMP9 signaling.
Wen Z; Liang C; Pan Q; Wang Y
Int J Mol Med; 2017 Nov; 40(5):1315-1322. PubMed ID: 28901379
[TBL] [Abstract][Full Text] [Related]
18. Synergistic regulation of vertebrate muscle development by Dach2, Eya2, and Six1, homologs of genes required for Drosophila eye formation.
Heanue TA; Reshef R; Davis RJ; Mardon G; Oliver G; Tomarev S; Lassar AB; Tabin CJ
Genes Dev; 1999 Dec; 13(24):3231-43. PubMed ID: 10617572
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of Eyes Absent Homolog 4 expression induces malignant peripheral nerve sheath tumor necrosis.
Miller SJ; Lan ZD; Hardiman A; Wu J; Kordich JJ; Patmore DM; Hegde RS; Cripe TP; Cancelas JA; Collins MH; Ratner N
Oncogene; 2010 Jan; 29(3):368-79. PubMed ID: 19901965
[TBL] [Abstract][Full Text] [Related]
20. Transcription coactivator Eya2 is a critical regulator of physiological hypertrophy.
Lee SH; Kim J; Ryu JY; Lee S; Yang DK; Jeong D; Kim J; Lee SH; Kim JM; Hajjar RJ; Park WJ
J Mol Cell Cardiol; 2012 Mar; 52(3):718-26. PubMed ID: 22197309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]